The art of discovering medicines
Vasant 'Vas' Narasimhan is a physician and CEO of the $50 billion Swiss pharma giant Novartis AG. In this conversation with Mint editor-in-chief Sruthijith KK, he discusses the company's direction under him, its presence in and plans for India, battling the extreme odds in drug discovery, the role his Indian heritage played in his life and work, and much more.
